Bariatric Surgery in Patients with Type 2 Diabetes: A Viable Option

References

• . Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195–1200
   PubMed Web of Science ®Google Scholar
• . Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–787
   PubMed Web of Science ®Google Scholar
• . Ferchk CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes—a systematic review. Diabetes Metab Res Rev. 2004;20(6):438–445
   Google Scholar
• . Ogden CL, Carroll MD, Curtain LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–1555
   PubMed Web of Science ®Google Scholar
• . Flegal KM. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav. 2005;86(5):599–602
   PubMed Web of Science ®Google Scholar
• . Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053
   PubMed Web of Science ®Google Scholar
• . Neel J. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–362
   PubMed Web of Science ®Google Scholar
• . Speakman JR. Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the ‘drifty gene’ hypothesis. Int J Obes. 2008;32(11):1611–1617
   Web of Science ®Google Scholar
• . Grundy SM, Cleeman JL, Daniels SR, ; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and Management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published corrections appear in Circulation 2005;112(17):e297 and 2005;112: e298]. Circulation. 2005;112(17):2735–2752
   PubMed Web of Science ®Google Scholar
• . Lementowski PW, Zelicof SB. Obesity and osteoarthritis. Am J Orthop (Belle Mead NJ). 2008;37(3):148–151
   PubMedGoogle Scholar
• . Muzumdar H, Rao M. Pulmonary dysfunction and sleep apnea in morbid obesity. Pediatr Endocrinol Rev. 2006;3( suppl 4):579–583
   PubMedGoogle Scholar
• . Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–1529
   PubMed Web of Science ®Google Scholar
• . Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Ann Intern Med. 2000;160(7):898–904
   Google Scholar
• . Alberti KG, Eckel RH, Grundy SM, . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task Force on Epidemiology and Prevention; National Heart, Lung, and Blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645
   PubMed Web of Science ®Google Scholar
• . Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003;144(12):5159–5165
   PubMed Web of Science ®Google Scholar
• . Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid induced insulin resistance in human resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and lkappaB-alpha. Diabetes. 2002;51(7):2005–2011
   PubMed Web of Science ®Google Scholar
• . Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917–932
   PubMed Web of Science ®Google Scholar
• . Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes. 1986;35(9):990–998
   PubMed Web of Science ®Google Scholar
• . Dixon JB, Pories WJ, O'Brien P, Schauer PR, Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care. 2005;28(2):472–474
   PubMedGoogle Scholar
• . Pories WJ, Swanson MS, MacDonald KG, . Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–350
   PubMed Web of Science ®Google Scholar
• . Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006;91(11):4223–4231
   PubMedGoogle Scholar
• . Rodriguez-Grunert L, Galvao Neto GP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4(1):55–59
   PubMedGoogle Scholar
• . Gersin KS, Keller JE, Stefanidis D, . Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14(4):275–278
   Google Scholar
• . Giard J. The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions. Diabetes Metab. 2008;34(6 pt 1):550–559
   Google Scholar
• . Buchwald H, Braunwald E, Pories FW, . Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737
   PubMed Web of Science ®Google Scholar
• . Dixon JB. Referral for a bariatric surgical consultation: it is time to set a standard of care. Obes Surg. 2009;19(5):641–644
   Google Scholar
• . Long SD, O'Brien K, MacDonald KG, . Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care. 1994;17(5):372–375
   Google Scholar
• . Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocinol Metab. 2008;93:S89–S96
   PubMed Web of Science ®Google Scholar
• . Sjostrom L, Lindroos AK, Peltonen M, . Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Eng J Med. 2004;351:2683–2693
   PubMed Web of Science ®Google Scholar
• . Pinkey JH, Kerrigan D. Current status of bariatric surgery in the treatment of type 2 diabetes. Obes Rev. 2004;5(1):69–78
   Google Scholar
• . Adams TD, Gress RE, Smith SC, . Long-term mortality after gastric bypass surgery. N Eng J Med. 2007;357(8):753–761
   PubMed Web of Science ®Google Scholar
• . Dixon JB, O'Brien PE, Playfair J, . Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–323
   PubMed Web of Science ®Google Scholar
• . Batsis JA, Romero-Corral A, Collazo-Clavell ML, Sarr MG, Somers VK, Lopez-Jimenez F. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83(8):897–906
   PubMed Web of Science ®Google Scholar
• . Cummings DE, Overduin J, Foster-Schubert KE, . Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89(6):2608–2615
   PubMed Web of Science ®Google Scholar
• . de Paula AL, Macedo AL, Prudenta AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)—pilot study of a new operation. Surg Obes Relat Dis. 2006;2(4):464–467
   Google Scholar
• . Ramos AC, Galvao Neto MP, de Souza YM, . Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI less than 30 kg/m2 (LBMI). Obese Surg. 2009;19(3):307–312
   Google Scholar
• . Schauer PR, Burguera B, Ikramuddin S, . Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–485
   PubMed Web of Science ®Google Scholar
• . Deitel M. From bariatric to metabolic surgery in non-obese subjects: time for some caution. Arq Bras Endocrinol Metab. 2009;53(2):246–251
   Google Scholar
• . Mason EE. Ileal transposition and enteroglucagon/BLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9(3):223–228
   Google Scholar
• . Cohen RV, Schiavon GA, Pinheiro JS, Correa JL, Rubino F. Duodenal-jejunal bypass for the treatment of type 2 diabetes with BMI 22–24 kg/m2: a report of two cases. Surg Obes Relat Dis. 2007;3(2):195–197
   PubMed Web of Science ®Google Scholar
• . Rubino F, Kaplan LM, Schauer PR, Cummings DE; Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405
   Google Scholar
• . American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32( suppl 1):S13–S61
   PubMed Web of Science ®Google Scholar
• . Folli F, Pontiroli AE, Schweisinger WH. Metabolic aspects of bariatric surgery. Med Clin North Am. 2007;91(3):393–414
   PubMed Web of Science ®Google Scholar
• . Rubino F, Gagner M, Gentileschi P, . The early effect of the Roux-en-Y gastric bypass on hormones involved in the body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–242
   PubMed Web of Science ®Google Scholar
• . Rubino F, Forgione A, Cummings DE, . The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741–749
   PubMed Web of Science ®Google Scholar
• . Thaler JP, Cummings DE. Hormonal mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150(6):2518–2525
   Google Scholar
• . Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes. JAMA. 2008;299(3):341–343
   Google Scholar
• . Ferrannini E, Mingrove G. Impact of different bariatric surgical procedures on insulin action and beta cell function in type 2 diabetes. Diabetes Care. 2009;32(3):515–520
   Google Scholar
• . Pratt GM, McLees B, Pories WJ. The ASBS Bariatric Surgery Centers of Excellence Program: a blueprint for quality improvement. Surg Obes Relat Dis. 2006;2:497–503
   Google Scholar
• . Heber D, Greenway FL, Kaplan LM, . Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline. J Clin Endocrinol and Metab. 2010;95(11):4823–4843
   PubMed Web of Science ®Google Scholar
• . ; Allied Health Sciences Section Ad Hoc Nutrition CommitteeAills L, Blankenship J, Buffington C, Furtado M, Parrott J. ASMBS Allied Health Nutritional Guidelines for the Surgical Weight Loss Patient. Surg Obes Relat Dis. 2008;4( 5 suppl):S73–S108
   Google Scholar
• . Mechanick J, Kushner R, Sugerman H, . American Association of Clinical Endocrinologists, The Obesity Society, and the American Society for Metabolic and Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support for the bariatric surgery patient. Surg Obes Relat Dis. 2008;4( 5 suppl):S109–S184
   PubMed Web of Science ®Google Scholar
• . Sogg S, Mori DL. The Boston interview for gastric bypass: determining the psychological suitability of surgical candidates. Obes Surg. 2004;14(3):370–380
   Google Scholar
• . Pratt J, Lender C, Dionne E, . Best practice update for pediatric/adolescent weight loss surgery. Obesity. 2009;17(5):901–910
   PubMed Web of Science ®Google Scholar
• . de Jager J, Kooy A, Lehert P, . Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181
   PubMed Web of Science ®Google Scholar
• . Rhode BM, Tamin H, Gilfix BM, Sampalis JS, Nohr C, MacLean LD. Treatment of vitamin B12 deficiency after gastric surgery for severe obesity. Obes Surg. 1995;5(2):154–158
   Google Scholar
• . Sjostrom L, Narbro K, Sjostrom CD, . Effects of bariatric surgery on mortality on swedish obese subjects. New Engl J Med. 2007;(357):741–752
   Google Scholar
• . Kopp HP, Kopp CW, Festa A, . Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscl Thromb Vasc Biol. 2003;23(6):1042–1047
   PubMed Web of Science ®Google Scholar
• . Primrose JN, Davies JA, Prentice CR, Hughes R, Johnson D. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost. 1992;68(4):396–399
   PubMed Web of Science ®Google Scholar
• . Kopp CW, Kopp HP, Steiner S, . Weight loss reduces tissue factor in morbidly obese patients. Obes Res. 2003;11(8):950–960
   PubMedGoogle Scholar
• . ; The Longitudinal Assessment of Bariatric Surgery (LABS) ConsortiumFlum DR, Belle SH, King WC, . Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–454
   Google Scholar
• . Livingston EH. Bariatric surgery outcomes at designated centers of excellence vs nondesignated programs. Arch Surg. 2009;144(4):319–325
   Google Scholar
• . Picot J, Jones J, Colquitt JL, . The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41): 1–190, iii–iv
   Web of Science ®Google Scholar
• . Tice JA, Karliner L, Walsh J, Petersen AJ. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885–893
   Google Scholar
• . Colagiuri R, Colagiuri S, Yach D, Pramming S. The answer to diabetes prevention: science, surgery, service delivery, or social policy? Am J Public Health. 2006;96(9):1562–1569
   PubMed Web of Science ®Google Scholar
• . Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology. 2001;120:669–681
   PubMed Web of Science ®Google Scholar